• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    AstraZeneca PLC - American Depositary Shares (NQ:AZN)

    82.40 +0.06 (+0.07%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about AstraZeneca PLC - American Depositary Shares

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    73 74 Next >
    AstraZeneca Reportedly Nears Drug Pricing Deal With President Trump
    Via Stocktwits
    UK Weighs 25% Rise In Drug Prices As Pharma Giants Pause Investments
    UK ministers consider raising NHS drug spending by up to 25% amid pharma investment delays and pressure from US pricing policies. 
    Via Benzinga
    Pfizer (NYSE:PFE) Marks 348th Consecutive Dividend Payment: A Pillar of Stability Amidst Transformation
    New York, NY – October 9, 2025 – Pfizer Inc. (NYSE:PFE) has once again affirmed its steadfast commitment to shareholder returns, declaring a $0.43 per-share cash dividend for the fourth quarter of... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Government
    Pfizer's 348th Consecutive Dividend: A Beacon of Stability Amidst Industry Headwinds
    New York, NY – October 9, 2025 – Pfizer Inc. (NYSE: PFE) has once again affirmed its steadfast commitment to shareholder returns, declaring a $0.43 per-share cash dividend for the fourth quarter of... 
    Via MarketMinute
    Topics Economy Intellectual Property Retirement
    AstraZeneca Announces $4.5B Investment In Virginia
    Via Stocktwits
    AstraZeneca Plans Ordinary Share Listing In US – Find Out More On The Harmonized Listing Structure
    Via Stocktwits
    AstraZeneca Expands Virginia Investment To $4.5 Billion For Cancer, Obesity Drugs
    AstraZeneca will invest $4.5 billion in a Virginia facility, creating 3,600 jobs and producing advanced cancer and metabolic medicines using AI and automation. 
    Via Benzinga
    Topics Artificial Intelligence
    Trump Administration Engages Pharmacies, GoodRx For TrumpRx Launch
    Pharmacies and GoodRx are in talks to join TrumpRx, a new drug pricing site aiming to lower prescription costs for U.S. consumers. 
    Via Benzinga
    Topics Government
    AstraZeneca plans to increase investment and scope of its Virginia manufacturing facility to $4.5 billion, creating 3,600 new jobs
    From AstraZeneca
    Via Business Wire
    A Look Into AstraZeneca Inc's Price Over Earnings
     
    Via Benzinga
    Should You Forget Nvidia and Buy These 2 Millionaire-Maker Stocks Instead?
    These two up-and-coming tech stocks just might make investors more money over the next decade than Nvidia will. 
    Via The Motley Fool
    Topics Artificial Intelligence
    Ionis Pharmaceuticals (NASDAQ:IONS) Ascends to Six-Year High, Fueled by Breakthrough Pipeline and Robust Sales Outlook
    Carlsbad, CA – October 8, 2025 – Ionis Pharmaceuticals (NASDAQ:IONS) is currently witnessing a remarkable surge in its stock value, nearing a six-year high. This impressive ascent is largely driven by... 
    Via MarketMinute
    AstraZeneca's Baxdrostat Shows Meaningful Blood Pressure Control In Patients With Resistant Hypertension
    AstraZeneca's Baxdrostat cut 24-hour systolic blood pressure in a Phase 3 trial, showing promise for treatment-resistant hypertension patients. 
    Via Benzinga
    Baxdrostat met the primary endpoint in Bax24 Phase III trial in patients with resistant hypertension
    From AstraZeneca
    Via Business Wire
    Amgen To Offer Cholesterol Drug At 60% Discount As Trump Administration's Call To Lower Drug Prices
    Amgen launches AmgenNow, offering Repatha at $239 per month, expanding direct access for U.S. patients with no insurer restrictions. 
    Via Benzinga
    Topics Government
    AstraZeneca Taps Gene Editing And AI Platform For Drug Discovery For Immunology Diseases
    Algen Biotechnologies partners with AstraZeneca in a $555 million deal to advance AI-driven CRISPR drug discovery and novel immunology therapies. 
    Via Benzinga
    Topics Artificial Intelligence
    AstraZeneca/Daiichi Sankyo Partnered Breast Cancer Drug Shows Survival Benefit Over Chemotherapy
    AstraZeneca and Daiichi Sankyo's Datroway improved survival outcomes over chemotherapy in advanced triple-negative breast cancer patients. 
    Via Benzinga
    Are Pure Play Quantum Computing Stocks a Buy in October?
    Quantum stocks have mooned in 2025, raising questions about whether their sky-high valuations reflect real breakthroughs or just speculation. 
    Via The Motley Fool
    DATROWAY® (datopotamab deruxtecan-dlnk) improved OS and PFS in TROPION-Breast02
    From AstraZeneca
    Via Business Wire
    FDA Greenlights Jazz and Roche's Zepzelca-Tecentriq for ES-SCLC Maintenance, Reshaping Lung Cancer Treatment Landscape
    In a pivotal moment for oncology, the U.S. Food and Drug Administration (FDA) on October 2, 2025, granted approval for the innovative combination of Jazz Pharmaceuticals' (NASDAQ: JAZZ) Zepzelca... 
    Via MarketMinute
    Navigating the Future: Unlocking Investment Opportunities in High-Growth Sectors
    As of October 2025, the global financial markets are undergoing a profound transformation, driven by an accelerating wave of technological innovation and a pressing global imperative for... 
    Via MarketMinute
    Topics Artificial Intelligence Climate Change Economy
    2 Under-The-Radar Health-Tech Stocks With Surging Momentum Scores
    Two under-the-radar health-tech stocks are seeing their Momentum scores surge in Benzinga's Edge Stock Rankings. 
    Via Benzinga
    Investing in These 3 Quantum Computing Stocks Could Be a Once-in-a-Lifetime Opportunity
    All of these rising quantum computing stars could be massive winners over the long run. 
    Via The Motley Fool
    Amgen Surges on Repatha Expansion, Manufacturing Boost, and Strong Earnings
    Thousand Oaks, CA – October 2, 2025 – Amgen (NASDAQ: AMGN) has witnessed a robust surge in its share price, climbing approximately 6% in recent trading sessions, culminating on October 2, 2025, to... 
    Via MarketMinute
    Topics Economy Intellectual Property Stocks
    AstraZeneca Stock Is Up 10% on Tariff News. But Is the Pharmaceutical Giant a Buy?
    The uncertainty about U.S. pharmaceutical tariffs shouldn't be as worrisome for AstraZeneca now. 
    Via The Motley Fool
    Topics Government World Trade
    Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
    September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Government
    Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk
    The U.S. pharmaceutical industry is at the center of a policy maelstrom. 
    Via Benzinga
    Topics ETFs
    AstraZeneca's Strategic Listing Harmonization: A Unified Global Platform for Growth
    AstraZeneca (LSE: AZN, NASDAQ: AZN) has announced a significant strategic move to harmonize its stock market listings across the London Stock Exchange (LSE), Nasdaq Stockholm (STO), and the New York... 
    Via MarketMinute
    Topics Economy
    GSK Leaps Into Buy Zone On Surprise Departure Of CEO Emma Walmsley
    Shares had broke out earlier this month, but have floundered at the lower boundary of the chart pattern. 
    Via Investor's Business Daily
    AstraZeneca Moves From ADRs To NYSE Listing
    The Board of AstraZeneca plc (NASDAQ: AZN) is recommending to shareholders a Harmonized Listing Structure for the company's ordinary shares across the London Stock Exchange (LSE), Nasdaq Stockholm... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    73 74 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.